and human (h)a3b2, but not ha7 nAChR subtypes expressed in Xenopus oocytes with the following selectivity: ra1b1dε > ra1b1dg z ha3b2 >> ha7. Our study emphasizes the importance of loop size and a-conotoxin sequence specificity for receptor binding. These studies can be used for the evaluation of the neuropharmacology of novel a-conotoxins that can be utilized as molecular probes for diseases such as, Alzheimer's, Parkinson's, and cancer.
Introduction
Predatory marine mollusks of the genus Conus (cone snails) produce a potent and complex venom, largely composed of highly modified peptides (conopeptides and conotoxins) that interact with a variety of molecular targets within their prey such as, K þ channels, Na þ channels, Ca 2þ channels, and nicotinic acetylcholine receptors (nAChRs), among others (Akondi et al., 2014; Lewis et al., 2012; Marí and Tytgat, 2010) . The venom of each Conus species contains over 2000 unique conopeptides spanning over 30 conotoxin gene superfamilies (Biass et al., 2009; Robinson and Norton, 2014) . There are seven classes of conotoxins that target nAChRs (Lebbe et al., 2014) . However, a-conotoxins are the quintessential nAChR inhibitors found in the venom of most species of cone snails (Akondi et al., 2014) . These peptides are 12e19 amino acids in length with two loops formed by the cysteine arrangement of C1-C3 and C2-C4 forming disulfide bonds (McIntosh et al., 1999) .
Several a-conotoxins are used as molecular probes to inhibit nAChRs with preferential inhibition towards specific subtypes depending upon the a-conotoxin in question (Cuny et al., 2017; Heghinian et al., 2015) . Such specificity has greatly advanced our knowledge of cholinergic-mediated mechanisms of neurological conditions such as Alzheimer's disease, schizophrenia, nicotine addiction, and depression disorders (Taly and Charon, 2012; Valles and Barrantes, 2012; Quik et al., 2015) . One a-conotoxin, Vc1.1, has ABBREVIATIONS: HPLC, high performance liquid chromatography; GF, giant fiber; GFS, giant fiber system; DLM, dorsal longitudinal muscle; nAChR, nicotinic acetylcholine receptor.
reached phase IIA clinical trials as a neuropathic pain therapeutic (Castro et al., 2017; Livett et al., 2006) .
The fruit fly is an ideal model organism for studying conotoxins due to the small amounts of venom necessary to elicit responses and the extensive number of studies that have been carried out on the neurobiology of these flies. We have previously described a novel bioassay to characterize conotoxins by pairing the in vivo nanoinjection of the conotoxins with simultaneous collection of electrophysiological recordings from the Drosophila melanogaster giant fiber system (GFS) (Mejia et al., 2010 (Mejia et al., , 2012 . The GFS is a wellcharacterized neuronal circuit responsible for the mediation of the fly's escape response. The circuit terminating on two muscles, the Dorsal Longitudinal Muscle (DLM) and the Tergo Trochanteral Muscle (TTM), contains three types of neurons with respect to synaptic transmission. The Giant Fiber (GF) innervates the Tergo Trochanteral Motor neuron (TTMn) and the Peripheral Synapsing Interneuron (PSI) via mixed electrical and cholinergic chemical synapses but the connections are predominantly dependent on gap junctions. In contrast, the synapse between the PSI and Dorsal Longitudinal motor neuron (DLMn) is solely dependent upon the Drosophila a7 nAChR (Heghinian et al., 2015) , a homolog of the human a7 nAChR (Fayyazuddin et al., 2006) , whereas the motor neurons use glutamate as a neurotransmitter.
We have previously demonstrated selective disruption of the GF-DLM but not the TTM pathway by several a-conotoxins from different Conus species confirming that this assay is an effective and specific screening method for a-conotoxins (Mejia et al., 2013 ).
Here we report the isolation of one known a-conotoxin (PIA) and two novel a-conotoxins (PIC and PIC[O7] ) and their direct in vivo characterization in the D. melanogaster GFS. We also determined the activity of PIC and PIC[O7] at rodent and human nAChR subtypes and PIA at human a7 nAChRs expressed in Xenopus laevis oocytes. All three a-conotoxins were isolated from the injected venom of Conus purpurascens, the only fish-hunting cone snail species found in the tropical Eastern Pacific region. The a-conotoxins of C. purpurascens act synergistically with other paralytic components (the motor cabal) to produce a flaccid paralysis as part of the mechanism of envenomation used to secure the prey. The disruption of cholinergic pathways is central to the mechanism of envenomation used by cone snails. Their associated neuropharmacology is still unraveling.
Methods and materials

Conotoxin extraction
The injected venom was "milked" from a single live C. purpurascens individual using the protocol established previously (Hopkins et al., 1995) . Briefly, the snail was enticed with a feeder gold fish until the proboscis was extended, and then the fish was replaced with a "trap" made from a microcentrifuge tube with the opening covered in latex and a fish tail. The snail was able to sense the fish tail and sting the trap, injecting its venom into the microcentrifuge tube. The care and maintenance of the gold fish followed the Institutional Animal Care and Use Committee (IACUC) guidelines established at Florida Atlantic University. The injected venom was collected once a week with an average volume of 10 mL and stored at À80 C until needed.
Isolation of conotoxins by RP-HPLC
PIA, PIC, and PIC[O7] were isolated by RP-HPLC from the injected venom of a single C. purpurascens individual (Fig. 1) by pooling the venom from several "milkings" to obtain a total volume of 50 mL. (Rodriguez et al., 2015) .
Conotoxin sequencing by Edman degradation
An aliquot corresponding to PIC and PIC[O7] fractions were dried, re-dissolved in 0.1 M Tris-HCl (pH 6.2), 5 mM EDTA, and 0.1% sodium azide, and reduced with 6 mM dithiothreitol. Following incubation at 60 C for 30 min, the sample was alkylated in a final volume of 15 mL with 20 mM iodoacetamide and 2 mL of NH 4 OH (pH 10.5) at room temperature (20e24 C) for 1 h in the dark. The reduced/alkylated peptides were dried and re-dissolved in 15 mL of water for sequencing by Edman degradation on an Applied Biosystems Procise model 491A sequencer.
In vivo electrophysiology in the Drosophila melanogaster giant fiber
The paired method of electrophysiology and nanoinjection in D. melanogaster has been described previously (Mejia et al., 2012 (Mejia et al., , 2013 . Briefly, wild-type flies (w
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, fly stocks #3605 obtained from the Bloomington Drosophila Stock Center) were kept at 25 C in vials with standard media. The a-conotoxins were prepared in 0.7% saline to a final concentration that allowed for the desired pmol of peptide to be injected. a-Conotoxins PIA, PIC, and PIC [O7] were injected at various concentrations into the hemolymph of the fly while simultaneously recording from the GFS. Control flies were injected with 0.7% saline solution without peptide. The GFs were stimulated in the brain with 10 trains of 10 stimuli given at 100 Hz with 1 s intervals between trains and the GF-DLM and GF-TTM pathways were monitored for changes in the following frequency (FF). Muscle response was monitored before and 1, 5, 10, 15, and 20 min after injection (n ¼ 10 for all experiments). Sigma Plot (Systat Software, San Jose, CA, USA) was used to perform the statistical analysis using a nonparametric Kruskal-Wallis 1-way ANOVA and Tukey test.
In vitro electrophysiology in Xenopus oocytes expressing nAChRs
Oocyte preparation and nAChR subunit expression in Xenopus oocytes were performed as described previously (Heghinian et al., 2015) . Briefly, plasmids with cDNA encoding the rat (a1, b1, g and d), mouse (ε) and human (a7, a3 and b2) nAChR subunits were linearized for in vitro mRNA synthesis using mMESSAGE mMA-CHINE kit (Ambion, Foster City, CA, USA). Oocytes were injected with 5 ng cRNA two to five days before recording and kept at 18 C in ND96 buffer (96 mM NaCl, 2 mM KCl, 1 mM CaCl 2 , 1 mM MgCl 2 and 5 mM HEPES, at pH 7.4) supplemented with 5% fetal bovine serum (Bovogen Biologicals, East Keilor, VIC, Australia), 50 mg/L gentamycin (GIBCO, Grand Island, NY, USA) and 10,000 U/mL penicillin-streptomycin (GIBCO, Grand Island, NY, USA). Voltage-recording and current-injecting microelectrodes were pulled from GC150T-7.5 borosilicate glass (Harvard Apparatus Ltd., Holliston, MA, USA) giving tip resistances of 0.3e1.5 MU when filled with 3 M KCl. Two-electrode voltage clamp recordings from oocytes were conducted at room temperature (22e23 C) using a GeneClamp 500B amplifier, Digidata 1322A interface and pClamp 9 software (Molecular Devices, Sunnyvale, CA, USA) at a holding potential of À80 mV.
Initially, oocytes in a 10 mL recording chamber were continuously perfused with ND96 solution at 2 ml/min, applied by a pump perfusion system. nAChR-mediated currents were evoked by applications of acetylcholine (ACh) at half-maximal effective concentration (EC 50 ) of 1 mM for rodent muscle, 6 mM for ha3b2 and 100 mM for ha7 nAChRs. Oocytes were preincubated with peptide for 5 min with the perfusion system turned off, followed by coapplication of ACh and peptide with flowing bath solution. Washout with bath solution occurred for 3 min between ACh applications. All peptide solutions were prepared in ND96 þ 0.1% bovine serum albumin. Peak ACh-evoked current amplitudes before (ACh alone) and after (ACh þ peptide) peptide incubation were measured using Clampfit version 10.7.0.3 software (Molecular Devices, Sunnyvale, CA, USA), where the ratio of ACh þ peptideevoked current amplitude to ACh alone-evoked current amplitude was used to assess the activity of PIA, PIC and PIC[O7] on AChevoked currents. All electrophysiological data were pooled and represent means ± standard error of the mean (SEM). Data sets were compared using an unpaired Student's t-test (GraphPad Prism 7, GraphPad Software, La Jolla, CA, USA). Differences were regarded statistically significant when p < 0.05.
Homology modeling of PIA and PIC bound to the Da7 nAChR receptor
Homology modeling of PIA and PIC bound to the Da7 nAChR were done with Modeler v9.18 (Webb and Sali, 2014 ) using a method described previously (Heghinian et al., 2015) . Briefly, the Xray crystal structure of Aplysia californica acetylcholine binding protein (AChBP) bound to a-conotoxin ImI (PDB ID: 2C9T) was used as a binding template (Ulens et al., 2006) . Chimera v.6.1 was used for the molecular graphics analysis (Yang et al., 2012) .
Transcriptome of the C. purpurascens venom duct
RNA was extracted from freshly dissected venom duct tissue and prepared utilizing the Illumina PolyA-Truseq preparation protocol. Samples were then sequenced on a Next-Seq 500 Illumina sequencing platform to produce four sets of paired end sequences. All runs were concatenated to produce two single independent datasets containing 31 million forward and reverse reads. Quality metrics were obtained using FASTQC and read distribution statistics were calculated with BBMap to prove accurate group fragment pair distance (141 bp) for read assembly. The paired-end data was then assembled using De-Bruijn graph based De Novo assembler, Trinity (Grabherr et al., 2011) , to produce a final FASTA dataset containing 64,321 independent assembled contigs. Final assembled contigs were then converted to a BLAST database using NCBI Blastþ and full protein sequences were identified using local NCBI BLASTx with an e-value cutoff of e À7 .
Results
Isolation and sequencing of PIA, PIC and PIC[O7]
The RP-HPLC profile of the injected venom from a single individual of C. purpurascens is shown in Fig. 1 Fig. 2A and B, n ¼ 10). PIA displayed the most significant disruption of the GF-DLM responses at 88 pmol/fly ( Fig. 2A) compared to the 0.7% saline control injection while having no effect on the GF-TTM pathway (Fig. 1S) . At this concentration, a-PIA decreases the probability of DLM responses to 9.8 ± 4.4% and 4.2 ± 0.2% at 10 and 20 min post injection, respectively. To determine the effects of a-PIA at lower concentrations, 67, 44, and 21 pmol of PIA/fly were injected as well, which caused a reduced dose-dependent inhibition of the GF-DLM pathway. At the lowest concentration tested, the DLM response probability was reduced to 67.7 ± 11.8% by 10 min and 47.0 ± 8.0% by 20 min post injection. PIC caused less inhibition of the GF-DLM pathway at 88 pmol/fly than PIA. Although PIC caused the DLM response to decreased to 69.5 ± 16.5% after 20 min post-injection when compared to the 0.7% saline control, an ANOVA analysis followed by a Tukey test showed that these measurements were not statistically significant when compared to the control. PIC[O7] at a concentration of 88 pmol/fly, exhibited no significant inhibition of the DLM response probability.
Similar to a-PIA, the GF-TTM pathway was unaffected by both, PIC and PIC[O7] (Fig. 1S) .
In vitro electrophysiology activity of PIC and PIC[O7] at heterologously expressed nAChRs in Xenopus oocytes
a-Conotoxins PIC and PIC[O7] were tested at vertebrate human (h)a3b2, ha7, rodent (r)a1b1dg, and ra1b1dε nAChR subtypes. PIA was tested at the ha7 nAChR using ImI as a positive control. We investigated the effects of the a-conotoxins on ACh-evoked currents mediated by nAChR subunit combinations expressed in Xenopus oocytes (Fig. 3A and B) . At 1 mM, a-conotoxins PIC and PIC[O7] reversibly inhibited ACh-evoked currents mediated by ra1b1dε nAChR by 59.8 ± 7.7% and 64.1 ± 4.6% (n ¼ 3), respectively. Both conotoxins also inhibited the ha3b2 and ra1b1gd nAChR subtypes by~30e45% whereas, only minimal inhibition (<10%) was observed at the ha7 nAChR subtype. At 1 mM, a-conotoxin PIA reversibly inhibited ha7 mediated ACh-evoked currents by < 10% (n ¼ 4), whereas, a-conotoxin ImI, used as a positive control on the same oocytes and at the same concentration, reversibly inhibited > 80% (82.7 ± 2.2%, n ¼ 4) of ACh-evoked current amplitude. In summary, PIC and PIC[O7] inhibited the muscle and neuronal nAChRs with the following selectivity sequence: ra1b1dε > ra1b1dg z ha3b2 >> ha7 (Table 1) . Surprisingly, PIC[O7] caused a slightly greater inhibition of ra1b1dε and ra1b1dg than PIC.
Molecular interactions of PIA and PIC at the Da7 nAChR
The interactions between PIA, PIC and the Da7 nAChR were further rationalized by homology modeling based upon the crystal structure of Aplysia californica AChBP bound to a-conotoxin ImI (Brejc et al., 2001; Ulens et al., 2006) , a suitable surrogate to study nAChR-conotoxin interactions. The key residues of PIA that determine binding to Da7 nAChR are predicted to be Asn7 and Val9 at the Da7 principal side, and Ser6 and Val12 at the Da7 complementary side of the binding pocket. These residues are predicted to bind to the receptor primarily through hydrogen bonding (Fig. 4A , red) and hydrophobic interactions (Fig. 4A, orange) . This model predicts that PIA (yellow) is essentially 'glued' to the interfaces of Da7 at the C-loop of the principal side (Fig. 4A, light blue) and binding pocket of the complementary side (Fig. 4A, dark blue) . The homology model of PIC and Da7 predicts fewer conotoxin-receptor interactions (Fig. 4B) , only one interaction with the C-loop of the principal side through Arg13 in PIC. Additional residues of PIC that determine binding to Da7 are predicted to be Pro7 at the Da7 principal side, and Lys11 at the Da7 complementary side of the binding pocket.
Discussion
The injected predatory venom of cone snails is a complex mixture of components that act synergistically to immobilize the prey. The functional characterization of such components is a major challenge, as these components are expressed in minute quantities and their direct neuropharmacological assessment, especially when using in vivo assays, is typically unreachable. Nevertheless, we have devised a Drosophila-based in vivo assay that permits the evaluation of picomole venom quantities. This assay is particularly suitable for the characterization of a-conotoxins, as the GF-DLM pathway (flight response) and not the GF-TTM (jump response) will be affected by a-conotoxins. Interestingly, not all a-conotoxins affect the Drosophila a7 nAChR in the same manner, as we have recently demonstrated for a panel of a-conotoxins from different species (Heghinian et al., 2015; Mejia et al., 2010 Mejia et al., , 2013 ).
Cone snails express a variety of a-conotoxins that in turn have can have differential inhibition profiles for the nAChRs present in the prey. The particular individual of C. purpurascens analyzed here expresses the known a4/7-conotoxin PIA and two new ones, PIC and its hydroxylated analog PIC[O7]. PIC and PIC[O7] are a4/4-conotoxins with four amino acid residues between each cysteine loop. This is the same cysteine loop arrangement as PIB (Table 1) , a known inhibitor of muscle-subtype nAChRs located at the mammalian neuromuscular junction (Lopez-Vera et al., 2007) . a- (1 mM) inhibition of AChevoked peak current amplitude mediated by ra1b1dε, ra1b1dg, ha3b2 and ha7 subtypes (mean ± SEM, n ¼ 3, *p < 0.05, **p < 0.0001). Testing of the a4/4-conotoxins PIC and PIC[O7] at nAChR subtypes expressed in Xenopus oocytes showed that these conotoxins preferentially inhibit the rodent muscle nAChRs more than the human neuronal nAChR subtypes (see Fig. 3 ). This explains the lack of PIC and PIC[O7] activity at the neuronal nAChRs compared to a-PIA, a known neuronal nAChR subtype inhibitor. The Da7 nAChR is a "neuronal-like" subtype, most similar to the mammalian a7 subtype (Heghinian et al., 2015) . However, Da7 has been sensitive to most a-conotoxins tested to date.
These two lineages of a-conotoxins from the venom of C. purpurascens with varying activity between neuronal and neuromuscular nAChRs may partially explain the lower potency of PIC for the Da7 nAChR when compared to PIA. PIA is a a4/7-conotoxin with low sequence homology to the 4/4 counterparts and the longer second loop may be the cause of the difference in selectivity towards the Da7 nAChR (Cuny et al., 2016) . Synthetic a-PIA does not inhibit human a1b1dε and it has low selectivity towards rat a3b2 nAChRs when compared to a6b2b3 (Dowell et al., 2003) . In this study, we show that native PIA was inactive at the human a7 nAChR. Synthetic conotoxins may exhibit different folding patterns and posttranslational modifications from the native peptide, which could account for differences in sensitivity and activity (Kang et al., 2007; Khoo et al., 2012) . It is important to note that in this study we evaluate the in vivo activity of conotoxins, which may differ from their activity in single cells. The nAChR C-loop is essential in linking the conformational changes that occur when the endogenous acetylcholine ligand binds to the receptor to the open the pore. Homology models of the complex between Da7 and PIA predict multiple interactions at the principal and complementary binding sites that resulted in locking the C-loop in a resting position hindering ACh binding and hampering the conformational changes needed for the channel to open (Celie et al., 2005) . As a result, synaptic transmission is inhibited leading to reduced DLM response. In contrast, the model of complex between Da7 and PIC showed diminished interactions between PIC and the C-loop, which is consistent with PIC noninhibitory activity when compared to PIA. While these models provide a rational for such interactions, the precise interaction of conotoxins with nAChRs can vary depending on the specific nAChR subtype and specific conotoxin in consideration.
This study accounts for the efficacious application of the GFS assay, where injected venom components of C. purpurascens were used to complete the in vivo assay. Here we have described the isolation of picomole quantities a-conotoxins PIA, PIC, and PIC[O7] from the injected venom of a single individual of C. purpurascens and the corresponding in vivo functional characterization in a Drosophila-based functional assay that involves the Da7 nAChR subtype. PIA is a known selective a6b2b3 and to a lesser extent a a3b2 nAChR inhibitor, but we have shown that PIA also inhibits the Da7 nAChR. We have also shown that the novel a-conotoxin PIC and its hydroxylated counterpart PIC[O7] have no significant inhibitory activity at Da7 nAChRs. At ra1b1dε and ra1b1gd nAChRs, PIC[O7] is a slightly more potent inhibitor than PIC suggesting that proline hydroxylation plays a delicate role in the mechanism of nAChR inhibition by a-conotoxins (Franco et al., 2006) .
We have demonstrated that the Drosophila-based in vivo assay can be used to functionally characterize minute quantities of aconotoxins. These findings can be readily correlated with vertebrate cholinergic pathways (Heghinian et al., 2015; Thany et al., 2007) . The GFS assay is an effective tool for in vivo screening of aconotoxins, with the advantage of using picomole quantities of the native natural product inhibitors. Furthermore, future studies can be envisioned through genetic manipulations of the Da7 nAChR, allowing structure-activity relationship studies for a-conotoxins and nAChR subtypes, which ultimately can be used for the evaluation of the neuropharmacology of novel a-conotoxins that can be utilize as molecular probes for diseases such as Alzheimer's, Parkinson's, and cancer.
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